TLR2 and type 1 diabetes mellitus: DC exposure to a TLR2 ligand enhanced CD4+CD25+ Treg proliferation, and treatment of pre-diabetic mice with a synthetic TLR2 agonist diminished the onset of T1D, and increased the number and function of CD4+CD25+ Treg [30, 38, 39].